<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Background </plain></SENT>
<SENT sid="1" pm="."><plain>In a previous study we identified 206 patients with colorectal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in the Northern Cape province of South Africa, diagnosed between January 2002 and February 2009 </plain></SENT>
<SENT sid="2" pm="."><plain>The age-standardised incidence was 4.2/100 000 per year world standard population </plain></SENT>
<SENT sid="3" pm="."><plain>This is 10% of the rate reported in First-World countries </plain></SENT>
<SENT sid="4" pm="."><plain>In high-incidence areas, the rate of <z:mp ids='MP_0009797'>abnormal mismatch repair</z:mp> gene expression in <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> is 2 - 7% </plain></SENT>
<SENT sid="5" pm="."><plain>Objectives </plain></SENT>
<SENT sid="6" pm="."><plain>The aim of this study was to determine the prevalence of hMLH1- and hMSH2-deficient <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> in the Northern Cape </plain></SENT>
<SENT sid="7" pm="."><plain>Methods </plain></SENT>
<SENT sid="8" pm="."><plain>Formalin-fixed paraffin wax-embedded tissue blocks from 87 colorectal <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> identified in the previous study were retrieved </plain></SENT>
<SENT sid="9" pm="."><plain>Standard immunohistochemical staining methods were used to detect the expression of hMLH1 and hMSH2 (i.e. products of the hMLH1 and hMSH2 genes) in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> using heat-induced antigen retrieval and diaminobenzidene as a chromogen </plain></SENT>
<SENT sid="10" pm="."><plain>Results </plain></SENT>
<SENT sid="11" pm="."><plain>In 8 blocks there was insufficient <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> tissue and in 1 case the immunohistochemical staining failed, probably owing to poor fixation, leaving 78 cases for analysis </plain></SENT>
<SENT sid="12" pm="."><plain>In 11 cases hMLH1 was deficient and in 6 cases hMSH2 was deficient </plain></SENT>
<SENT sid="13" pm="."><plain>Overall, 21.8% of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> were deficient for hMLH1 or hMSH2 </plain></SENT>
<SENT sid="14" pm="."><plain>Conclusion </plain></SENT>
<SENT sid="15" pm="."><plain>Presuming that 80% of <z:hpo ids='HP_0000001'>all</z:hpo> hMLH1 deficiencies are due to hypermethylation of the gene, we found 10.5% of <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> in an area with a low incidence of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> to be deficient in the product of the mismatch repair gene/s </plain></SENT>
<SENT sid="16" pm="."><plain>This is approximately three times the reported rate in high-incidence areas </plain></SENT>
</text></document>